| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/25/2010 | CA2737549A1 Compositions and methods for modulating toll-like receptor activity |
| 03/25/2010 | CA2737456A1 Pharmaceutical compositions and related methods of delivery |
| 03/25/2010 | CA2737448A1 Use of ctgf as a cardioprotectant |
| 03/25/2010 | CA2737392A1 Use of a compound capable of reducing the uric acid level for the prevention and/or the treatment of lung inflammation and fibrosis |
| 03/25/2010 | CA2736774A1 Nutritional support to prevent and/or mitigate bone marrow toxicity from a cancerous tumor |
| 03/25/2010 | CA2736747A1 Nutritional support to prevent or moderate bone marrow paralysis or neutropenia during anti-cancer treatment |
| 03/25/2010 | CA2736438A1 Tyrosine kinase receptor tyro3 as a therapeutic target in the treatment of cancer |
| 03/24/2010 | EP2166745A2 Bit mask generation system and printer drivers and printing methods incorporating bit masks generated utilising same |
| 03/24/2010 | EP2166744A2 Bit mask generation system and printer drivers and printing methods incorporating bit masks generated utilising same |
| 03/24/2010 | EP2166096A2 Moraxella (Branhamella) catarrhalis antigens |
| 03/24/2010 | EP2166095A2 Antisense oligonucleotides capable of inhibiting the formation of capillary tubes in endothelial cells |
| 03/24/2010 | EP2166093A1 Pharmaceutical composition for enzyme replacement therapy |
| 03/24/2010 | EP2166087A2 FAD4, FAD5, FAD5-2 et FAD6, fatty acid desaturase family members and uses thereof |
| 03/24/2010 | EP2166020A1 Peptide having hypotensive activity |
| 03/24/2010 | EP2166019A2 Immunisation against Chlamydia Pneumoniae |
| 03/24/2010 | EP2166017A1 Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues |
| 03/24/2010 | EP2165716A1 Novel bone mass increasing agent |
| 03/24/2010 | EP2165715A1 Therapeutic agent for cancer, and method for treatment of cancer |
| 03/24/2010 | EP2165713A1 Whey and thymus function |
| 03/24/2010 | EP2165711A1 Methods for treating bleeding disorders using sulfated polysaccharides |
| 03/24/2010 | EP2165710A1 Tyrosine kinase receptor Tyro3 as a therapeutic target in the treatment of a bladder tumor |
| 03/24/2010 | EP2165705A1 Use of a compound capable of reducing the uric acid level for the prevention and/or the treatment of lung inflammation and fibrosis |
| 03/24/2010 | EP2165698A1 Cosmetic composition designed to protect damaged skin |
| 03/24/2010 | EP2165605A1 Use of a ribonuclease of the T2 family having actin-binding activity for inhibiting and/or reversing proliferation |
| 03/24/2010 | EP2165198A2 Cosmetic use of apolipoprotein d type proteins |
| 03/24/2010 | EP2164866A1 Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues |
| 03/24/2010 | EP2164862A1 Clostridial toxin netb |
| 03/24/2010 | EP2164861A1 Process for providing a temperature - stable muscle relaxant on the basis of the neurotoxic component of botulinum toxin |
| 03/24/2010 | EP2164858A1 Novel compounds, use thereof in cosmetic and cosmeceutic applications, and compositions comprising same |
| 03/24/2010 | EP2164532A2 Use of a haemoglobin for the preparation of dressings and resulting dressings |
| 03/24/2010 | EP2164519A2 Long-acting polymeric prodrugs of exendin |
| 03/24/2010 | EP2164509A1 Igf for the treatment of rett syndrome and synaptic disorders |
| 03/24/2010 | EP2164507A1 Treatment of allergic disease with immunomodulator compounds |
| 03/24/2010 | EP2164506A2 Specific therapy and medicament using integrin ligands for treating cancer |
| 03/24/2010 | EP2164473A1 An extended-release composition comprising a somatostatin derivative in microparticles |
| 03/24/2010 | EP2164467A2 Slow release pharmaceutical composition made of microparticles |
| 03/24/2010 | EP2164459A1 Stable non-aqueous pharmaceutical compositions |
| 03/24/2010 | EP2164330A1 Serca2 therapeutic compositions and methods of use |
| 03/24/2010 | EP2081566B1 Improved biological effects of compositions comprising rosmarinic acid |
| 03/24/2010 | EP1755660B1 Method for enhancing or inhibiting insulin-like growth factor-i |
| 03/24/2010 | EP1697403B1 Haemophilus influenzae type iv pili |
| 03/24/2010 | EP1620060B1 Methods and devices for the sustained release of multiple drugs |
| 03/24/2010 | EP1180938B1 Agents, compositions and methods utilizing the same useful in treating or preventing alzheimer disease |
| 03/24/2010 | EP1075496B1 Binding molecules derived from immunoglobulins which do not trigger complement mediated lysis |
| 03/24/2010 | EP1003370B1 Method of enhancing magnesium absorption and prevention of atherosclerosis |
| 03/24/2010 | CN101679988A Fusion proteins binding to growth factors |
| 03/24/2010 | CN101679980A variant activin receptor polypeptides and uses thereof |
| 03/24/2010 | CN101679975A proteins from the webs of nephilengys cruentata, avicularia juruensis and parawixia bistriata spiders |
| 03/24/2010 | CN101679505A Variants derived from actriib and uses therefor |
| 03/24/2010 | CN101679502A A new type of consensus interferon and preparation method thereof |
| 03/24/2010 | CN101679501A methods of treating, diagnosing and detecting fgf21-associated disorders |
| 03/24/2010 | CN101679499A Anti-tumor drug, medicament, composition, and use thereof |
| 03/24/2010 | CN101679498A bis-met histones |
| 03/24/2010 | CN101679495A Short bio-active peptides for cellular and immunological modulation |
| 03/24/2010 | CN101679487A Peptides and their use |
| 03/24/2010 | CN101679483A Hydrazido-peptides as inhibitors of hcv ns3-protease |
| 03/24/2010 | CN101678213A Cyclic peptide cxcr4 antagonists |
| 03/24/2010 | CN101678106A Combination of Blys inhibition and/or APRIL inhibition and immunnosuppressants for treatment of autoimmune disease |
| 03/24/2010 | CN101678102A Combined human il- 18 and anti cd20 antibody cancer treatment |
| 03/24/2010 | CN101678099A Therapeutic compositions for boosting the effect of antibody therapy against the epidermal growth factor receptor |
| 03/24/2010 | CN101678093A Vaccine for the prevention of breast cancer relapse |
| 03/24/2010 | CN101678089A Use of matrix metalloproteinase-10 (MMP-10) for thrombolytic treatments |
| 03/24/2010 | CN101678088A Modified mutant collagenase and it's use in fat melting and in scar reduction |
| 03/24/2010 | CN101678087A Obligate heterodimer meganucleases and uses thereof |
| 03/24/2010 | CN101678086A 固体纤维蛋白原制剂 The solid fibrinogen preparation |
| 03/24/2010 | CN101678085A The use of alkaline phosphatase in the treatment of reduced renal function |
| 03/24/2010 | CN101678084A Unacylated ghrelin as therapeutic agent in the treatment of metabolic disorders |
| 03/24/2010 | CN101678083A pharmaceutical formulations of ghrh molecules |
| 03/24/2010 | CN101678082A Methods for promoting protection and regeneration of bone marrow using CXCL9 and anti-CXCL9 antibodies |
| 03/24/2010 | CN101678081A Calcium flux as a pharmacoefficacy biomarker for inhibitors of histone deacetylase |
| 03/24/2010 | CN101678080A Therapeutic effects of bryostatins, bryologs, and other related substances on ischemia/stroke-induced memory impairment and brain injury |
| 03/24/2010 | CN101678079A Modified erythropoietin polypeptides and uses thereof for treatment |
| 03/24/2010 | CN101678078A SPARC and methods of use thereof |
| 03/24/2010 | CN101678077A Novel antiphlogistic-analgesic agent |
| 03/24/2010 | CN101678076A Use of the augmenter of liver regeneration protein as an apoptosis regulator |
| 03/24/2010 | CN101678075A Cell migration, cell infiltration, or neovascularization inhibitor through degradation of function of ptk7 protein |
| 03/24/2010 | CN101678074A Novel use of ec-sod and method for preparing thereof |
| 03/24/2010 | CN101678073A Methods and compositions for use of cyclic analogues of histatin |
| 03/24/2010 | CN101678072A methods of treating infection |
| 03/24/2010 | CN101678071A Prophylactic agent for renal failure |
| 03/24/2010 | CN101678070A Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma |
| 03/24/2010 | CN101678069A Treatment of allergic disease with immunomodulator compounds |
| 03/24/2010 | CN101678068A Treating stroke and other diseases without inhibiting n-type calcium channels |
| 03/24/2010 | CN101678067A nell-1 enhanced bone mineralization |
| 03/24/2010 | CN101678066A Stabilization of liquid solutions of recombinant protein for frozen storage |
| 03/24/2010 | CN101678065A Vaccine therapy for choroidal neovascularization |
| 03/24/2010 | CN101678064A Methods of treating or preventing emesis using growth hormone secretagogues |
| 03/24/2010 | CN101678063A Methods of use of epsilon inhibitor compounds for the attenuation of pain |
| 03/24/2010 | CN101677978A Methods of correcting imbalance between bone resorption and bone formation and kits and compositions therefor |
| 03/24/2010 | CN101677965A An extended-release composition comprising a somatostatin derivative in microparticles |
| 03/24/2010 | CN101677959A Slow release pharmaceutical composition made of microparticles |
| 03/24/2010 | CN101677948A Intranasal carbetocin formulations and methods for the treatment of autism |
| 03/24/2010 | CN101677947A pharmaceutical formulation comprising an insulin derivative |
| 03/24/2010 | CN101677537A disintegrin variants and pharmaceutical uses thereof |
| 03/24/2010 | CN101676299A Peptides and/or proteins and use thereof for the production of a therapeutic and/or prophylactic medicament |
| 03/24/2010 | CN101676298A 黑皮质素受体配体 Melanocortin receptor ligands |
| 03/24/2010 | CN101676297A Preparation method of sea cucumber active polypeptide under ultrasonic extraction |
| 03/24/2010 | CN101675992A Beta-amyloid-analogue-t-cell epitop vaccine |
| 03/24/2010 | CN101675991A Liquid composition of modified factor vii polypeptides |
| 03/24/2010 | CN101675936A Immunosuppressant |